AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 173 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $940,000 | -35.0% | 29,000 | 0.0% | 0.21% | -32.1% |
| Q2 2019 | $1,447,000 | -26.0% | 29,000 | 0.0% | 0.30% | -29.6% |
| Q1 2019 | $1,956,000 | +46.3% | 29,000 | 0.0% | 0.43% | +30.0% |
| Q4 2018 | $1,337,000 | -40.2% | 29,000 | 0.0% | 0.33% | -27.3% |
| Q3 2018 | $2,236,000 | -8.5% | 29,000 | 0.0% | 0.46% | -14.7% |
| Q2 2018 | $2,443,000 | +3.0% | 29,000 | 0.0% | 0.54% | +1.9% |
| Q1 2018 | $2,372,000 | +43.1% | 29,000 | 0.0% | 0.53% | +43.6% |
| Q4 2017 | $1,658,000 | -14.4% | 29,000 | 0.0% | 0.37% | -19.3% |
| Q3 2017 | $1,936,000 | +29.8% | 29,000 | 0.0% | 0.46% | +21.0% |
| Q2 2017 | $1,492,000 | – | 29,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| NORTHCAPE WEALTH MANAGEMENT, LLC | 10,510 | $241,415 | 0.09% |